Benedetta Bussolati Selected Research

Benedetta Bussolati Research Topics

Disease

36	Neoplasms (Cancer) 01/2020 - 06/2003
7	Renal Cell Carcinoma (Grawitz Tumor) 04/2019 - 08/2002
6	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2008
5	Inflammation (Inflammations) 01/2017 - 08/2002
5	Hypoxia (Hypoxemia) 01/2017 - 01/2012
4	Pre-Eclampsia (Preeclampsia) 01/2022 - 05/2008
4	Proteinuria 03/2010 - 10/2002
4	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2009 - 09/2006
3	Hypertension (High Blood Pressure) 01/2022 - 01/2009
3	Rhabdomyolysis 07/2017 - 05/2013
3	Neoplasm Metastasis (Metastasis) 02/2017 - 08/2011
3	Anaplastic Thyroid Carcinoma 01/2017 - 02/2012
3	Breast Neoplasms (Breast Cancer) 01/2016 - 06/2006
3	Necrosis 03/2010 - 10/2002
3	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2010 - 04/2002
2	Endometriosis 02/2022 - 12/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 05/2019
2	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 12/2014
2	Kidney Neoplasms (Kidney Cancer) 04/2019 - 04/2018
2	Fibrosis (Cirrhosis) 01/2017 - 11/2016
2	Chronic Renal Insufficiency 01/2017 - 06/2015
2	Carcinoma (Carcinomatosis) 10/2008 - 09/2006
2	Infections 03/2008 - 10/2002
1	Heart Failure 01/2022
1	Pathologic Neovascularization 01/2022
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	COVID-19 01/2020
1	Hereditary Nephritis (Alport Syndrome) 01/2020
1	Death (Near-Death Experience) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 06/2019
1	Vascular Remodeling 06/2019
1	Polyuria 05/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Adenocarcinoma of Lung 02/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2017

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 02/2004
7	matrigelIBA 01/2019 - 02/2004
7	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2004
5	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2011
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014 - 04/2002
3	Biological ProductsIBA 05/2021 - 04/2002
3	Sunitinib (Sutent)FDA Link 04/2018 - 12/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 12/2008
3	Pharmaceutical PreparationsIBA 01/2017 - 03/2010
3	Glycerol (Glycerine)FDA LinkGeneric 11/2016 - 10/2010
3	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2010 - 04/2006
3	nephrinIBA 01/2009 - 05/2008
2	Therapeutic UsesIBA 02/2022 - 06/2013
2	AntigensIBA 01/2022 - 12/2019
2	Angiogenesis InhibitorsIBA 12/2019 - 08/2011
2	CalciumIBA 06/2019 - 04/2008
2	Small Interfering RNA (siRNA)IBA 02/2017 - 07/2013
2	Erythropoietin FDA Link 11/2016 - 07/2013
2	Sorafenib (BAY 43-9006)FDA Link 12/2014 - 12/2012
2	Histone Deacetylase InhibitorsIBA 07/2012 - 02/2012
2	Messenger RNA (mRNA)IBA 09/2011 - 02/2006
2	Immunoglobulin A (IgA)IBA 03/2010 - 02/2003
2	Peptides (Polypeptides)IBA 02/2009 - 08/2007
2	CytokinesIBA 01/2009 - 08/2008
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2008 - 10/2006
2	Platelet Activating FactorIBA 10/2007 - 08/2002
2	Oxytocin (Pitocin)FDA LinkGeneric 06/2006 - 04/2002
1	Hormones (Hormone)IBA 02/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 02/2022
1	quinagolideIBA 02/2022
1	EndoglinIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	histidine-rich proteinsIBA 01/2021
1	Apolipoprotein L1IBA 01/2021
1	3-hydroxycholest-7-ene-14-carbaldehydeIBA 01/2021
1	Desoxycorticosterone Acetate (DOCA)FDA Link 03/2020
1	SaltsIBA 03/2020
1	dicarboxydine (DCD)IBA 01/2020
1	CollagenIBA 01/2020
1	Transient Receptor Potential ChannelsIBA 07/2019
1	Adenosine Triphosphate (ATP)IBA 06/2019
1	AlbuminsIBA 05/2019
1	Histamine Antagonists (Antihistamines)IBA 05/2019
1	bilastineIBA 05/2019
1	CreatinineIBA 05/2019
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 05/2019
1	CreatineIBA 05/2019
1	Tyrosine Kinase InhibitorsIBA 11/2018
1	Monoclonal AntibodiesIBA 04/2018
1	carotuximabIBA 04/2018
1	fluorescein-isothiocyanate sinistrinIBA 07/2017
1	isothiocyanic acidIBA 07/2017
1	sinistrinIBA 07/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2017
1	Caveolin 1IBA 02/2017
1	CaveolinsIBA 02/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2017

Therapy/Procedure

18	Therapeutics 01/2020 - 08/2007
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2016 - 06/2015
1	Subcutaneous Injections 01/2020